SaqqurM, TsivgoulisM, MolinaCAet al., the CLOTBUST Investigators. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multicenter study. Cerebrovasc Dis2009; 27:5–12.
2.
AlexandrovAGrottaJC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology2002; 59:862–7.
3.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. N Engl J Med1995; 333:1581–7.
4.
TopakianRGruberFFellnerFAHaringHPAichnerFT. Thrombolysis beyond the guidelines: two treatments in one subject within 90 hours based on a modified magnetic resonance imaging brain clock concept. Stroke2005; 36:e162–4.
5.
DerexLNighoghossianN. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry2008; 79:1093–9.
6.
KeeleyEBouraJGrinesC. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet2003; 361:13–20.
7.
GershlickAH, Stephens-LloydA, HughesSet al., for the REACT Trial Investigators.Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med2005; 353:2758–68.
8.
The IMS Study Investigators.Combined intravenous and intraarterial recanalization for acute ischaemic stroke: the Interventional Management of Stroke Study. Stroke2004; 35:904–12.
